FL S1386

Renames "pain-management clinics" to "controlled-substance medical clinics" and redefines them as facilities where a physician prescribes more than 25 Schedule II or III controlled substance prescriptions daily or dispenses controlled substances, with prohibition on advertising dispensing services.

Prohibits controlled-substance medical clinics from advertising services related to medication dispensing and removes requirements for physicians to complete pain-medicine fellowships or comply with specific fellowship training rules.

Changes prescription drug monitoring program reporting deadline from 15 days to 24 hours after dispensing controlled substances and establishes that the State Surgeon General (not the Office of Drug Control) appoints the board of directors for the direct-support organization.

Authorizes law enforcement agencies to request confidential prescription drug monitoring program information upon determination of probable cause and issuance of a search warrant, and allows law enforcement to disclose this information to criminal justice agencies under search warrant authority.

Allows Department of Health to obtain patient records without notification from controlled-substance medical clinics when probable cause exists that violations are occurring and obtaining authorization would jeopardize investigations.